Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVATE-AKI: Vitamin D for AKI
NCT02962102Phase 2Completed
- Start
- Apr 2017
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute kidney injury (AKI) comparing Calcifediol, Calcitriol and Placebo (3 arms). Primary endpoints: Death Within 7 Days, Number of Participants Who Received Renal Replacement Therapy Within 7 Days and 1 more. Started Apr 2017; status: completed.
02
Drugs
calcifediolcalcitriol
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02962102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962102.